MentionFox
Home › funding signals › Mercury Bio, Inc.
Form D · on the record

Mercury Bio — $3K Form D filing, February 2025

Before you sell to, join or invest in Mercury Bio, Inc.

MentionFox check on Mercury Bio, Inc.: only 1 source on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/mercury-bio-inc-form-d-25000002

Check Mercury Bio, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Mercury Bio, Inc.?

Based on the record MentionFox holds for this company. No flag is not a clearance.

Mercury Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2025-02-21.

Mercury Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on February 21, 2025. The filing reports $3K sold. Its industry group is Biotechnology. It names Paul Laur (Executive Officer, Director), Steve Kiziuk (Director), Alex Koglin (Director) (SEC Form D, February 21, 2025).

Sell to companies like Mercury Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

88 companies raised this week, 1 had other signals.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

fal - Features & Labels, Inc.$1BAI and software
fal - Features & Labels, Inc.$350MAI and software
SIERRA INTERNATIONAL NETWORK INC$300MAI and software
Zai Lab Ltd$250MBiotech
Databento Inc.$100MAI and software
Check one company free All companies that raised this week

5 more Biotechnology raises within 90 days of this one ↓

Is this your company?

Key facts

Run the free check on Mercury Bio, Inc. →

Mercury Bio, Inc.

New Form D on file · 2025-02-21 · the record

$3K
raise on the record
D
filing
1
investors in
NEW MEXICO
based
Open the record →

What the record says

FilingForm D
Filed2025-02-21
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
Year formed2020
BasedSANTA FE, NEW MEXICO
CIK1952927
Accession0001952927-25-000001

Pitching, partnering or investing alongside them? See who really runs and owns Mercury Bio, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Mercury Bio, Inc., from the filings we hold.

More raises like this

Biotechnology raises filed within 90 days of this one, largest first.

What do you want to do with Mercury Bio, Inc.?

Get the full cited report on Mercury Bio, Inc.

What the filing shows about Mercury Bio, Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 8 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Mercury Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look Mercury Bio, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Mercury Bio, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives Mercury Bio, Inc.'s address as 3900 Paseo Del Sol, Santa Fe, NM 87507.

What the filing says

  • Offered: $2,541. Sold: $2,541. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 1 had already invested. (filing)
  • Date of first sale: February 13, 2025. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Mercury Bio, Inc. See pricing

Is Mercury Bio, Inc. a real, registered company?

Mercury Bio, Inc. is a registered filer with the SEC (CIK 1952927) and has filed since 2022-11-14. 5 filings are on record, the latest on 2025-10-24.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Mercury Bio, Inc.?

Mercury Bio, Inc.'s Form D of 2025-02-21 names Paul Laur, Steve Kiziuk, Alex Koglin and 5 more as its officers, directors or promoters.

How much has Mercury Bio, Inc. raised?

Its new offerings report $3.88M sold across 5 offerings, as its own filings state.

Filing history · 5 filings on this registrant
Form D · 2022-11-14 · $200KForm D · 2023-02-17 · $1.15MForm D · 2024-04-03 · $150KForm D · 2025-02-21 · $3K · this pageForm D · 2025-10-24 · $2.38M 2022-11-14 2025-10-24

Each marker is one filing. The larger marker is the filing this page is about.

Biotechnology · by week

Trailing twelve months. 765 filings in Biotechnology, totalled by week.

Want the whole picture on Mercury Bio, Inc.?

What the filing shows about Mercury Bio, Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 8 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Mercury Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Mercury Bio, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Mercury Bio, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Mercury Bio, Inc.: Raised $3K, Form D filed 2025-02-21
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/mercury-bio-inc-form-d-25000002
Last updated 2026-11-05
Primary record: SEC filing 1 · SEC filing 2
Mercury Bio raised $3K — SEC Form D filing, February 2025. MentionFox, 2026-11-05. https://mentionfox.com/funding/mercury-bio-inc-form-d-25000002